Potential Drug-Drug Interaction (PDDI) Clinical Decision Support, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/PDDI-CDS/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
<ActivityDefinition xmlns="http://hl7.org/fhir">
<id value="ad204"/>
<language value="en"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<table class="narrative-table">
<tbody>
<tr>
<th colspan="2" scope="row" class="row-header">Metadata</th>
</tr>
<tr>
<th scope="row" class="row-header">Title</th>
<td class="content-container">ActivityDefinition AD204</td>
</tr>
<tr>
<th scope="row" class="row-header">Version</th>
<td class="content-container">1.0.0</td>
</tr>
<tr>
<th scope="row" class="row-header">Experimental</th>
<td class="content-container">true</td>
</tr>
<tr>
<th scope="row" class="row-header">Jurisdiction</th>
<td class="content-container">
001 from <a href="http://unstats.un.org/unsd/methods/m49/m49.htm">http://unstats.un.org/unsd/methods/m49/m49.htm</a>
</td>
</tr>
<tr>
<th scope="row" class="row-header">Steward (Publisher)</th>
<td class="content-container">HL7 International / Clinical Decision Support</td>
</tr>
<tr>
<th scope="row" class="row-header">Description</th>
<td class="content-container"><div><p>Digoxin-cyclosporine activity definition for Digoxin 0.125 MG</p>
</div></td>
</tr>
<tr>
<th scope="row" class="row-header">Resource Kind</th>
<td class="content-container">MedicationRequest</td>
</tr>
<tr>
<th scope="row" class="row-header">Product</th>
<td class="content-container">Digoxin 0.125 MG
</td>
</tr>
<tr>
<th colspan="2" scope="row" class="row-header">Generated using version 0.5.6-cibuild of the sample-content-ig Liquid templates</th>
</tr>
</tbody>
</table>
</div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
<valueCode value="cds"/>
</extension>
<url value="http://hl7.org/fhir/uv/pddi/ActivityDefinition/ad204"/>
<version value="1.0.0"/>
<name value="AD204"/>
<title value="ActivityDefinition AD204"/>
<status value="active"/>
<experimental value="true"/>
<date value="2026-06-17T14:03:14+00:00"/>
<publisher value="HL7 International / Clinical Decision Support"/>
<contact>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/dss"/>
</telecom>
</contact>
<description
value="Digoxin-cyclosporine activity definition for Digoxin 0.125 MG"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="001"/>
</coding>
</jurisdiction>
<kind value="MedicationRequest"/>
<participant>
<type value="practitioner"/>
</participant>
<productCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="315819"/>
<display value="Digoxin 0.125 MG"/>
</coding>
<text value="Digoxin 0.125 MG"/>
</productCodeableConcept>
</ActivityDefinition>